WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis

Portfolio Overview

As of March 31, 2026

Icon Portfolio

Asset Allocation

Equity: 98.05%Others: 1.95%
Icon Portfolio

Market Cap

Large Cap: 19.23%Small Cap: 40.42%Mid Cap: 28.27%Others: 10.13%
Icon Portfolio

Number of stocks

55
Icon Portfolio

Top 10 Holdings

54.47% of portfolio

Market Cap of Equity

Large Cap
19.23%
Small Cap
40.42%
Mid Cap
28.27%
Others
10.13%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd12.35%
J.B. Chemicals & Pharmaceuticals Ltd8.90%
Lupin Ltd5.77%
Divi's Laboratories Ltd5.31%
Apollo Hospitals Enterprise Ltd4.24%
Laurus Labs Ltd3.93%
Fortis Healthcare Ltd3.85%
Max Healthcare Institute Ltd Ordinary Shares3.79%
Glenmark Pharmaceuticals Ltd3.17%
Krishna Institute of Medical Sciences Ltd3.16%

Sector Allocation of Equity

Healthcare86.27%
Basic Materials7.20%
Equity4.58%

SIP Amount

Monthly SIP Date

WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.